The transaction expands Davion’s clinical operations into home healthcare and sets the stage for home-based noninvasive monitoring.
RT’s Three Key Takeaways
- Strategic Acquisition: Davion Healthcare agreed to acquire Philadelphia-based Healthcare Stat Homecare Inc for $13.5 million in cash and stock, according to a company news release.
- Service and Revenue Growth: The transaction provides Davion with an established home healthcare provider that reported $11.6 million in gross receipts for 2025, according to financial figures cited by the company.
- Remote Monitoring Opportunities: Davion plans to evaluate incorporating its non-invasive health monitoring technologies into home clinical care settings following the close of the deal, according to Davion executives.
Davion Healthcare Plc, a developer of noninvasive health monitoring technologies, has agreed to acquire Healthcare Stat Homecare Inc (HSH) for $13.5 million, according to a company news release.
Under the terms of the agreement dated Oct 27, 2026, the total consideration consists of $8 million in cash, and $5.5 million in Davion shares issued at an agreed value of $13 per share, the company reported. The transaction is expected to close on or before Dec 31, 2026, subject to customary closing terms outlined in the acquisition agreement, according to the release.
Based in Philadelphia, HSH operates as a licensed provider of skilled nursing, home health aide services, and rehabilitation therapies across Philadelphia and surrounding communities, according to the company. For the fiscal year ended Dec 31, 2025, HSH recorded unaudited gross receipts of approximately $11.6 million, and ordinary business income of approximately $1.9 million, the release stated.
According to Davion, the purchase marks the initial step in a planned acquisition strategy aimed at adding established, revenue-generating healthcare operating businesses over the coming year to complement its proprietary healthcare technology portfolio.
“HSH is an established and profitable business that will bring meaningful revenues and earnings to Davion, while giving us a direct presence in home healthcare and opportunities to introduce our monitoring and diagnostic technologies closer to patients. Importantly, this is the first in a planned programme of acquisitions of revenue-generating, profitable healthcare businesses over the coming year, as we look to build a broader and more diversified Group combining our proprietary technologies with established operating businesses. We look forward to working with HSH’s management to support its existing operations and explore opportunities to integrate our technologies into the delivery of care at home,” said Glenn Williams, chief executive officer of Davion, in a news release.
HSH maintains accreditation from the Joint Commission on Accreditation of Healthcare Organizations (JCAHO), holds Medicare and Medicaid certifications, and employs registered nurses, licensed practical nurses, home health aides, physical and occupational therapists, and social workers, according to information provided by the companies. Its clinical offerings include wound care, lymphedema management, dementia care, diabetes management, telehealth, and physical rehabilitation, delivering in-home support to pediatric through geriatric patient populations, the company reported.
The acquisition expands Davion’s scope beyond product development and into active clinical care delivery, creating opportunities to study and implement its non-invasive monitoring tools for wound assessment, preventative management, and remote home patient tracking following completion, according to the announcement.
“We share Davion’s commitment to improving care for patients outside hospital settings. Joining forces would give us an opportunity to combine HSH’s home healthcare experience with Davion’s technology-led approach, while continuing to focus on the quality and continuity of care we provide to patients and families,” said Manilal Mathai, co-owner and chief executive officer of HSH.
